Ozempic Pill Fails Alzheimer's Test

Novo Nordisk stock falls after setback in effort to expand uses for its obesity drug

- BY PETER LOFTUS AND ADRIA CALATAYUD

Novo Nordisk shares fell sharply after the Danish drugmaker said a pill with the key ingredient in Ozempic and Wegovy didn't slow Alzheimer's disease in two late stage clinical trials.